Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Oct 19;131(1):108–120. doi: 10.1182/blood-2017-07-791608

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2018 by The American Society of Hematology

PMC Copyright notice

Figure 5. — Evaluation of CD8⁺T cells transduced with constructs, including HA-1 TCR2, and safety switch and/or CD8 coreceptor and/or a selection marker. (A) Drawing illustrating the composition of the 5 different LV transgene constructs evaluated: (i) iCasp9(iC9)-HA1 TCR2; (ii) HA1 TCR2-CD8 coreceptor (CD8); (iii) iC9-HA1 TCR2-CD8; (iv) iC9-HA1 TCR2-RQR-CD8; and (v) iC9-CD34-HA1 TCR2-CD8. (B) Intracellular cytokine staining showing production of IL-2 and IFN-γ by CD8⁺ and CD4⁺ T cells transduced with the LV transgene constructs in response to HLA-A2/HA-1⁺ primary AML. (C) CRAs showing specific lysis of HLA-A2⁺/HA-1⁺ AML (AML 1-4) or HLA-A2⁺/HA-1^– AML (AML 5) by CD8⁺ T cells transduced with the LV transgene constructs.